Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
413
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Contact hypersensitivity
|
phenotype |
Skin and Connective Tissue Diseases
|
Pathologic Function
|
71
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Cerebral Ischemia
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
120
|
2
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Immediate hypersensitivity
|
phenotype |
Immune System Diseases
|
Pathologic Function
|
14
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Experimental Lung Inflammation
|
disease |
Infections; Respiratory Tract Diseases
|
Experimental Model of Disease
|
54
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Drug Eruptions
|
group |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
41
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Benign Neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
371
|
7
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Mouth Neoplasms
|
group |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
140
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Bright Disease
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
31
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Contact Dermatitis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
110
|
3
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Calcinosis
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
52
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
418
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Microcalcification
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
42
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Allergic Reaction
|
phenotype |
Immune System Diseases
|
Pathologic Function
|
197
|
1019
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Morbilliform Drug Reaction
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Tumoral calcinosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
45
|
3
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Alcoholic Intoxication
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
52
|
4
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hypersensitivity
|
group |
Immune System Diseases
|
Pathologic Function
|
90
|
2
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Autoimmune Chronic Hepatitis
|
disease |
Digestive System Diseases; Immune System Diseases
|
Disease or Syndrome
|
213
|
23
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |